Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261)

Ask supplier a question | View on supplier's website

Mapatumumab (Anti-TNFRSF10A / TRAILR1 / CD261) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) with apoptosis promoting and potential antitumor activities. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2332
Sku #	A2332-1mg
Pricing	1mg, $539.00

Feedback